Phase 3 trials for pancreatic cancer treatment

I reported previously (10th Jun) results of trials of one pancreatic treatment at Israel’s Sheba hospital. Sheba are now starting Phase 3 trials of another, CPI-613 (devimistat) from Israeli biotech Rafael, which can also treat Acute Myeloid Leukemia and other cancers.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *